AAP
PMI

Arax Advisory Partners’s Picard Medical PMI Stock Holding History

Arax Advisory Partners’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
+377
New +$8.01K ﹤0.01% 4708
2026
Q1 		– Hold
0
– – – 3750

Other funds holding PMI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Arax Advisory Partners's PMI Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Picard Medical (PMI) in Q2 2026: 377 shares worth $3.08K. The stake represents ﹤0.01% of the portfolio and ranks #4708 among its holdings.

36 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Arax Advisory Partners held 377 shares of Picard Medical worth $3.08K as of Q2 2026.
  • Picard Medical was a new Arax Advisory Partners position in Q2 2026.
  • Picard Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4708 holding.
  • 36 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.